Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for Aveanna Healthcare Holdings (AVAH) over the last 6 years, with Q3 2025 value amounting to $2.0 million.

  • Aveanna Healthcare Holdings' Capital Expenditures fell 876.64% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year increase of 1049.07%. This contributed to the annual value of $6.3 million for FY2024, which is 331.92% up from last year.
  • Aveanna Healthcare Holdings' Capital Expenditures amounted to $2.0 million in Q3 2025, which was down 876.64% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, Aveanna Healthcare Holdings' Capital Expenditures registered a high of $4.0 million during Q2 2022, and its lowest value of $1.1 million during Q3 2023.
  • In the last 5 years, Aveanna Healthcare Holdings' Capital Expenditures had a median value of $2.0 million in 2025 and averaged $2.1 million.
  • Per our database at Business Quant, Aveanna Healthcare Holdings' Capital Expenditures plummeted by 5996.45% in 2023 and then soared by 9636.2% in 2024.
  • Quarter analysis of 5 years shows Aveanna Healthcare Holdings' Capital Expenditures stood at $2.7 million in 2021, then grew by 20.56% to $3.2 million in 2022, then plummeted by 51.2% to $1.6 million in 2023, then dropped by 2.49% to $1.5 million in 2024, then surged by 32.05% to $2.0 million in 2025.
  • Its Capital Expenditures stands at $2.0 million for Q3 2025, versus $1.1 million for Q2 2025 and $2.3 million for Q1 2025.